The product principle: automate repetitive healthcare work without hiding consequential decisions from the people responsible for them.
The bottleneck was translation, not Excel.
Laboratory specialists defined biomarkers, ranges, thresholds, categories, and recommendations in spreadsheets. Engineering then interpreted the same rules and entered them into the product by hand. Every revision created another handoff.
I owned product definition and cross-functional delivery with laboratory, engineering, design, data, and operations partners. I chose a dual-path system: a structured editor for recurring work, plus an upload parser that preserved the laboratory team's familiar authoring workflow. Engineering approval remained a required state.
- Observed operational result: setup moved from approximately one month to one week, an estimated 75% shorter cycle.
- System effect: engineers shifted from repeated entry to review, approval, and exception handling.
Use AI for coordination, not clinical judgment.
Provider interviews pointed to the same pattern in small practices: clinicians were spending time on intake, reminders, refills, follow-ups, and status checks because they had little administrative support.
I had feature-level ownership for an AI-assisted practice workspace. I designed a template library, persistent patient context, refill controls, and an updates inbox organized around Issues, Reports, Operations, and Archived. The useful role for AI was assembling a low-risk workflow from clear building blocks. In this reconstruction, I make control explicit by asking the provider to review the trigger, patient scope, and action.
- Delivered scope: research, product definition, interaction design, and feature specifications.
- Evidence limit: the product launched after I left, so I do not claim post-launch adoption or business impact.
Trust is measurable at the point of control.
I would compare templates with manual setup using activation rate, completion rate, time to activation, provider edits before approval, disable or undo behavior, and escalations caused by ambiguous inputs. These are proposed measures, not historical results.
Company details are anonymized. The interface is a reconstructed portfolio prototype based on workflows I owned. The explicit review pattern shown here is a proposed production safeguard, not a claim about the shipped implementation.
Foundational health
Remind the patient 7 days before the prescription ends.
Illustrative interaction. It demonstrates template selection, patient context, and provider confirmation.